Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

14 Jul 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34261126
DOI: 10.1038/s41586-021-03807-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapePMID 34261126Read ↗

Ultra-potent RBM-specific single-domain antibody broadly neutralizes multiple SARS-CoV-2 variants with picomolar activitySemantic proximity Read ↗

Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeSemantic proximity Read ↗

Insights into SARS-CoV-2 evolution, potential antivirals, and vaccinesSemantic proximity Read ↗

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19Semantic proximity Read ↗

Antibody drugs targeting SARS-CoV-2: Time for a rethink?Semantic proximity Read ↗

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.Semantic proximity Read ↗

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesSemantic proximity Read ↗

Current status of therapeutic monoclonal antibodies against SARS-CoV-2.Semantic proximity Read ↗

Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance.Semantic proximity Read ↗

A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitopeSemantic proximity Read ↗

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsSemantic proximity Read ↗

SnapShot: SARS-CoV-2 antibodies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.